These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10701528)

  • 1. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
    DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
    J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
    Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.
    Jean WC; Spellman SR; Wallenfriedman MA; Flores CT; Kurtz BP; Hall WA; Low WC
    J Neurooncol; 2004 Jan; 66(1-2):39-49. PubMed ID: 15015768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
    Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12-based immunotherapy against rat 9L glioma.
    Jean WC; Spellman SR; Wallenfriedman MA; Hall WA; Low WC
    Neurosurgery; 1998 Apr; 42(4):850-6; discussion 856-7. PubMed ID: 9574650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.
    Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC
    J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.
    Smilowitz HM; Joel DD; Slatkin DN; Micca PL; Nawrocky MM; Youngs K; Tu W; Coderre JA
    J Neurooncol; 2000; 46(3):193-203. PubMed ID: 10902851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
    Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
    Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
    Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
    J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.
    Kulprathipanja NV; Kruse CA
    J Neuroimmunol; 2004 Aug; 153(1-2):76-82. PubMed ID: 15265665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma.
    Hsu W; Lesniak MS; Tyler B; Brem H
    J Neurooncol; 2005 Sep; 74(2):135-40. PubMed ID: 16193383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.
    Benedetti S; Bruzzone MG; Pollo B; DiMeco F; Magrassi L; Pirola B; Cirenei N; Colombo MP; Finocchiaro G
    Cancer Res; 1999 Feb; 59(3):645-52. PubMed ID: 9973213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
    Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME
    Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
    Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
    Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats.
    Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D
    Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.